Patients with heart failure, severe pulmonary hypertension, and a preserved ejection fraction of ≥50% had a worse prognosis when compared with other patients with heart failure and severe pulmonary hypertension.
For left ventricular assist device recipients, those on phosphodiesterase-5 inhibitors have a higher incidence of severe early right heart failure.
The American Heart Association and Heart Failure Society released a joint scientific statement summarizing the effects of type 2 diabetes management on heart failure outcomes.
The FDA has approved the use of Corlanor for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy in pediatric patients aged 6 months and older.
Viewing mild pulmonary hypertension as a high-risk clinical parameter in heart failure with preserved ejection fraction could pave a way forward for early intervention.
Investigators sought to categorize patients with nonobstructive coronary artery disease and heart failure separately from patients with heart failure with normal coronary arteries, so as to more specifically analyze risk for cardiovascular hospitalization and all-cause mortality.
Fibroblast growth factor 23 levels above the median are independently associated with shorter 6-minute walk distance and lower peak oxygen consumption on exercise testing, study finds.
Investigators sought to determine whether galectin-3 may effectively predict mortality and heart failure after a myocardial infarction.
Study demonstrated the feasibility of a newly designed mobile application for telemonitoring of patients after heart failure hospitalization.
HealthDay News — The burden of heart failure-related cardiovascular disease (CVD) mortality is increased among young and middle-aged blacks, according to a research letter published in the May 14 issue of the Journal of the American College of Cardiology. Peter Glynn, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined…